Your session is about to expire
← Back to Search
Cereset for Dementia Caregiver Stress
Study Summary
This trial will test whether a brain-targeted intervention called Cereset can help improve heart rate variability in caregivers of people with dementia who are experiencing stress, anxiety, or insomnia, as well as improve self-report measures of stress, sleep and caregiver burden.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I provide 10+ hours of care weekly to someone with dementia.I cannot sit comfortably for 75 minutes.I feel stressed, anxious, or have trouble sleeping and my scores on related tests are high.I am not on medications that could affect heart rate measurements.I haven't used any brain stimulation or feedback therapies in the last month.I do not have symptoms of stress, anxiety, or insomnia.I have not felt at risk of suicide in the last 3 months.I cannot or do not want to attend the study sessions.I can sit for 90 minutes and attend three sessions weekly for a month.I have had seizures or suicidal thoughts in the last 3 months.
- Group 1: Cereset Research
- Group 2: Control
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the primary goals that this clinical trial seeks to accomplish?
"The primary outcome of this trial, measured over the course of Baseline; V2 (0-14 days after intervention completion); and V3 (4-7 weeks following completion) is to gauge any changes in Blood Pressure Measurements. Secondary outcomes encompass Center for Epidemiologic Studies Depression Scale (CES-D), Perceived Stress Scale (PSS), and Caregiver Distress (NPI-Q). CES-D ranges from 0-60 with higher scores suggesting more depressive symptoms, PSS uses a 0-40 scale where lower values indicate less stress levels, and NPI-Q severity score can range between 0"
Is enrollment still available in this research endeavor?
"Reportedly, this clinical trial is presently recognizing applicants. It was initially announced on June 16th 2022 and has recently been revised on September 27th of the same year."
What is the current enrollment figure for this trial?
"That is correct. The clinicaltrials.gov website indicates that this medical trial, originally posted on June 16th 2022, is currently enrolling patients. 20 individuals are required from a single location."
Share this study with friends
Copy Link
Messenger